AMN vs REGN
AMN Healthcare Services Inc (AMN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AMN currently screens at market cap $1.23B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AMN and REGN stock pages for the full models.
Not investment advice.